Source-backed guidance on Xeomin and Daxxify safety, including FDA warnings, contraindications, provider verification, and emergency protocols for medical tourists.
Last reviewed: 2026-05-06
12 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Key takeaways
Both Xeomin and Daxxify carry FDA boxed warnings about distant spread of toxin effect, which can cause serious breathing and swallowing difficulties.
Absolute contraindications include known hypersensitivity to botulinum toxin, active infections, pregnancy, and neuromuscular diseases like myasthenia gravis.
Seek immediate medical attention if you experience blurred vision, drooping eyelids, difficulty swallowing, breathing problems, or muscle weakness after treatment.
Xeomin and Daxxify have similar safety profiles; Daxxify's effects may last longer, but both carry the same FDA boxed warning.
If you're looking for more information about botulinum toxin treatments, visit our botulinum toxin resource hub for comprehensive guides on different products, procedures, and considerations.
Understanding Xeomin and Daxxify Safety
Xeomin (incobotulinumtoxinA) and Daxxify (daxibotulinumtoxinA) are two of the six FDA-approved botulinum toxin products available for cosmetic and therapeutic use in the United States [S1]. Both products work by temporarily relaxing targeted muscles to reduce the appearance of wrinkles or treat certain medical conditions. To learn more about treatment options, visit our botox treatment pages.
As of 2025, the FDA has approved six cosmetic botulinum toxin products: Botox, Daxxify, Dysport, Jeuveau, Letybo, and Xeomin [S1]. While these products share similar mechanisms of action, each has distinct formulation characteristics that may influence how they are used in clinical practice.
Xeomin is unique in that it is a "naked" botulinum toxin without complexing proteins, while Daxxify uses a proprietary peptide exchange technology that may contribute to its longer duration of effect [S3]. Both products carry the same FDA boxed warning and should be approached with the same safety considerations.
The FDA Boxed Warning
Both Xeomin and Daxxify carry an FDA boxed warning—the most serious type of warning required by the regulatory agency—regarding the distant spread of toxin effect. This means the effects of botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects in other parts of the body [S3].
The boxed warning specifically alerts healthcare providers and patients that symptoms including swallowing difficulties (dysphagia), breathing difficulties, and muscle weakness have been reported hours to weeks after injection [S3]. In severe cases, death has been reported. This warning applies to all botulinum toxin products, regardless of whether they are used for cosmetic or therapeutic purposes.
Common vs. Serious Side Effects
Understanding the difference between common, mild side effects and serious complications is essential for safe treatment:
Common, typically mild side effects may include:
Temporary bruising or swelling at the injection site
Mild headache
Slight drooping of the eyelid (temporary)
Numbness or discomfort at the injection site
These effects are generally temporary and resolve within days to weeks [S2].
Serious complications that require immediate medical attention include the symptoms outlined in the Red Flags section below. The distinction matters because while most patients experience only mild, transient effects, serious reactions can occur even with proper administration of FDA-approved products [S1, S3].
Key Point
Both products are FDA-approved and have established safety profiles when administered by qualified professionals. However, the boxed warning exists because serious complications, while uncommon, can occur and may be life-threatening in extreme cases.
When NOT to Get These Injections
Certain individuals should not receive Xeomin or Daxxify treatments, or should only proceed after extensive consultation with their physician. Understanding these contraindications is essential for patient safety.
Absolute Contraindications
You should NOT receive these injections if you have [S2, S3]:
Known hypersensitivity to any botulinum toxin product or its components (such as human albumin or sucrose, which are used in some formulations)
Active infection at the proposed injection site
Pregnancy or breastfeeding (these treatments are generally not recommended)
Neuromuscular diseases including myasthenia gravis, Lambert-Eaton syndrome, or amyotrophic lateral sclerosis (ALS)
Relative Precautions and Higher-Risk Populations
Certain individuals face increased risk and should consult their physician before proceeding:
Individuals with a history of allergic reactions to other botulinum toxin products
Patients taking certain medications that may interact with botulinum toxin
Those with bleeding disorders or who take blood-thinning medications
People with significant facial asymmetry or underlying neurological conditions
The American Society of Plastic Surgeons notes that patients with any history of neurological disease should be evaluated carefully before receiving botulinum toxin injections, as they may be at increased risk for systemic effects [S4].
Important
If you have a neuromuscular disease such as myasthenia gravis or Lambert-Eaton syndrome, you face a higher risk of serious systemic effects from botulinum toxin. Always disclose your complete medical history to your provider and consult with your neurologist before considering treatment [S2, S3].
Pre-Treatment Medical Consultation
Before receiving treatment, discuss your complete medical history with your provider, including:
All current medications and supplements
Any history of botulinum toxin treatments
Neurological conditions or muscle disorders
Allergies, particularly to human albumin
Pregnancy status or plans
This conversation is essential for determining whether treatment is appropriate for your specific situation [S1, S2].
Red Flags: Warning Signs of Serious Complications
Recognizing the warning signs of serious complications can save your life. The CDC and medical experts identify specific symptoms that require immediate medical attention after receiving botulinum toxin injections.
Emergency Symptoms Requiring Immediate Care
Seek emergency medical attention if you experience [S1, S2]:
Blurred or double vision — this may indicate the toxin is affecting muscles around the eyes
Drooping eyelids (ptosis) — beyond the expected mild effect
Difficulty swallowing (dysphagia) — this can become severe and affect breathing
Difficulty breathing — this is a medical emergency
Muscle weakness in areas beyond the treatment site
Slurred speech — may indicate systemic toxin spread
Numbness or paralysis in untreated areas of the body
The CDC emphasizes that these symptoms have been reported hours to weeks after injection [S1]. Do not wait for symptoms to worsen—difficulty breathing and swallowing can become life-threatening rapidly.
Understanding Distant Spread of Toxin Effect
The mechanism behind serious complications involves the spread of botulinum toxin beyond the intended injection site. While the toxin is designed to affect only the targeted muscles, in rare cases it can travel through the bloodstream or neural pathways to affect distant muscles [S3].
This is why the FDA requires the boxed warning on all botulinum toxin products. The risk appears to be higher with:
Higher doses
Injections near large muscle groups
Certain underlying health conditions
Use of counterfeit or mishandled products
Botulism-Like Reactions
In extreme cases, the systemic effects of botulinum toxin can resemble botulism—a serious paralytic illness. Symptoms may include progressive paralysis starting from the face and moving downward, severe difficulty swallowing, and respiratory failure [S1, S2].
While these reactions are rare with properly administered FDA-approved products, they have been documented and can be fatal without prompt medical intervention.
Do Not Wait
If you experience difficulty breathing or swallowing after receiving botulinum toxin injections, call emergency services immediately. These symptoms can worsen rapidly and may become life-threatening.
Protecting Yourself: Provider and Product Verification
One of the most important steps you can take to ensure safe treatment is verifying the qualifications of your provider and the authenticity of the product used. This is especially important for patients traveling internationally for treatment.
How to Verify Your Provider Is Qualified
Before receiving treatment, verify that [S1, S4]:
Your provider holds a valid healthcare license in their jurisdiction
Your provider has specific training in administering botulinum toxin
The facility is appropriately licensed or accredited
The provider is willing to answer questions about their credentials
The American Society of Plastic Surgeons recommends that patients only receive injections from qualified healthcare professionals who are trained in the specific procedure [S4]. This is not the time to cut corners on verification.
Verifying FDA-Approved Products
Ask your provider the following questions [S1]:
Is this product FDA-approved for the intended use?
Can you show me the product packaging and lot number?
Where did you obtain this product?
Is this product purchased from a licensed distributor?
Legitimate providers should be transparent about the products they use and happy to answer these questions. If a provider is reluctant to provide this information, consider that a significant red flag.
Risks of Counterfeit Products
The CDC has reported increased harmful reactions from counterfeit or mishandled botulinum toxin products [S1]. These risks include:
Unknown dosage — counterfeit products may contain unpredictable amounts of toxin
Contamination — non-sterile products can cause infections
Improper formulation — products may contain harmful additives
Lack of quality control — no assurance of safety or efficacy
Counterfeit products are particularly common through unlicensed online sources. Never purchase botulinum toxin products online and never accept treatment with products you have not verified [S1]. The FDA has issued safety alerts about counterfeit botulinum toxin products being distributed through unauthorized channels, and these have been linked to hospitalizations and serious adverse events [S1].
Red Flags
Be suspicious of:
Prices that seem too good to be true
Providers who will not disclose product information
Treatments offered in non-medical settings
Products that arrive in unmarked or non-original packaging
Travel-Specific Considerations for International Patients
If you are considering treatment in Istanbul or another international destination, additional precautions are necessary:
Research the provider's credentials through official Turkish medical licensing authorities (the Turkish Medical Association maintains provider verification resources)
Confirm the facility meets international sanitation standards and has appropriate accreditation
Ensure FDA-approved products are used (or equivalent Turkish regulatory approval from TMMDA)
Verify that the product packaging is sealed and displays proper lot numbers before opening
Plan for follow-up care in case of complications—understand what aftercare is included and how to access care after you return home
Understand emergency medical protocols at your destination and know the local emergency number (112 in Turkey)
Consider bringing documentation of your treatment to share with your home physician
Request written documentation of the product name, dosage, and injection sites in English
Knowing what to do in an emergency can make a critical difference in outcomes. If you experience concerning symptoms after receiving Xeomin or Daxxify injections, take the following steps:
Immediate Action Steps
If you experience difficulty breathing, swallowing, or severe weakness, call emergency services immediately (dial 112 in Turkey, or your local emergency number) [S1].
If you experience vision changes, drooping eyelids, or moderate symptoms, contact your healthcare provider urgently and seek medical evaluation the same day.
Document your symptoms including when they started, the product used, the dosage, and the injection sites.
Bring your treatment documentation to any medical evaluation, including the product name, lot number, and provider information.
Reporting Adverse Events
Adverse events from botulinum toxin products should be reported to help improve patient safety:
In the United States: Report to the FDA MedWatch program
In Turkey: Report to the Turkish Medicines and Medical Devices Agency (TMMDA)
Reporting helps regulatory authorities track safety issues and protect other patients [S1].
Follow-Up Care
After experiencing any concerning symptoms:
Follow up with your physician even if symptoms improve
Inform all healthcare providers of your treatment history
Keep documentation of the event for your medical records
Pre-Treatment Checklist for Safe Results
Use this checklist before receiving Xeomin or Daxxify treatments to ensure you have taken appropriate safety precautions:
Questions to Ask Your Provider
[ ] What product will be used, and is it FDA-approved?
[ ] What are your credentials and training for administering botulinum toxin?
[ ] What is the source of this product?
[ ] What is the dosage and how many injection sites will be used?
[ ] What are the potential side effects specific to my treatment?
[ ] What should I do if I experience concerning symptoms?
[ ] What is your emergency contact information?
What to Expect During Consultation
A qualified provider should [S2, S4]:
Review your complete medical history
Discuss your goals and expectations
Explain the procedure and realistic outcomes
Review potential risks and complications
Provide written aftercare instructions
Schedule follow-up if needed
Documentation to Request
[ ] Product packaging showing FDA approval and lot number
[ ] Written record of the treatment including dosage and injection sites
[ ] Provider's credentials and license information
[ ] Aftercare instructions with emergency contact information
[ ] Information on how to report adverse events
Your Safety Is Priority
A qualified provider will welcome these questions and provide thorough, confident answers. If a provider seems evasive or rushed, consider that a warning sign and seek care elsewhere.
Comparing Xeomin and Daxxify Risk Profiles
Xeomin and Daxxify share the same FDA boxed warning and fundamental mechanism of action—both block nerve signals to muscles to reduce wrinkle-causing contractions. However, there are meaningful differences that may affect individual risk assessment:
Duration of Effect: Clinical data suggests Daxxify may provide results lasting longer than traditional botulinum toxin products, with some patients reporting effects up to 6 months compared to 3-4 months for Xeomin [S3]. This longer duration means any adverse effects, if they occur, may also persist longer.
Formulation Differences: Xeomin contains no complexing proteins, while Daxxify uses a proprietary peptide technology [S3]. Patients with sensitivities to specific formulation components should discuss these differences with their provider.
Dosing Considerations: Because Daxxify may last longer, the cumulative dosing over time may differ. This is a factor worth discussing with your provider, especially if you have concerns about long-term use.
Safety Profile: Both products have comparable safety profiles in clinical trials, with similar rates of common side effects like injection site bruising and headache [S3]. The boxed warning applies equally to both products.
Ultimately, the choice between Xeomin and Daxxify should be made in consultation with your provider, taking into account your individual medical history, treatment goals, and risk factors.
For personalized guidance on coordinating your medical travel to Istanbul—including provider verification and treatment planning—our team is here to help. Start Your Plan
